Soluble ST2 (sST2) and IL-33 in preeclampsia
Granne, I +5 more
openaire +2 more sources
Soluble ST2 as a biomarker for predicting severe adverse events among pediatric patients with Mycoplasma pneumoniae pneumonia. [PDF]
Cheng F +6 more
europepmc +1 more source
sST2 for Outcome Prediction in Acute Heart Failure
Alberto Aimo +3 more
openaire +1 more source
Evaluation of sST2 Levels in Infants of Mothers with Gestational Diabetes. [PDF]
Koyuncu E +6 more
europepmc +1 more source
Association between plasma concentrations of galectin 3, growth differentiation factor 15, soluble suppression of tumourigenicity 2, and cystatin C and clinical parameters and survival in patients with end-stage renal disease undergoing haemodialysis. [PDF]
Ptak M +8 more
europepmc +1 more source
Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas. [PDF]
García-Vioque V +14 more
europepmc +1 more source
Dual and context-dependent role of the interleukin-33/soluble suppression of tumorigenicity 2 axis in obesity and adipose tissue inflammation. [PDF]
Casado M +10 more
europepmc +1 more source
Diagnostic Value of Serum sST2 and MicroRNA-29a in Ovarian Cancer: A Dual-Biomarker Pilot Study. [PDF]
Akdeniz FT +5 more
europepmc +1 more source
BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension. [PDF]
Becher C +12 more
europepmc +1 more source
IL-33 Drives Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. [PDF]
Jankauskas SS +3 more
europepmc +1 more source

